biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > This Will Be Interesting

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Dec 13, 2022 3:19pm

152 Views

Post# 35169276

RE:RE:RE:RE:RE:This Will Be Interesting

narmac,

Trying to dig up as much positive stuff as you can to make yourself feel better about this?

Keep in mind you are going from 100% ownership to 11!!

And as for going to da moooooon I think you will be landing on the "dark" side!

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment